• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乌兹别克斯坦新患结核病患者和既往治疗过的结核病患者治疗效果不佳的相关因素:一项为期五年的全国性研究。

Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study.

作者信息

Gadoev Jamshid, Asadov Damin, Tillashaykhov Mirzagolib, Tayler-Smith Katie, Isaakidis Petros, Dadu Andrei, de Colombani Pierpaolo, Gudmund Hinderaker Sven, Parpieva Nargiza, Ulmasova Dilrabo, Jalolov Avazbek, Hamraev Atadjan, Ali Engy, Boom Martin van den, Hammerich Asmus, Gozalov Ogtay, Dara Masoud

机构信息

World Health Organization country office in Tashkent, Tashkent, Uzbekistan.

State Post Graduate Institute of Medical Education, Tashkent, Uzbekistan.

出版信息

PLoS One. 2015 Jun 15;10(6):e0128907. doi: 10.1371/journal.pone.0128907. eCollection 2015.

DOI:10.1371/journal.pone.0128907
PMID:26075615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4467982/
Abstract

BACKGROUND

TB is one of the main health priorities in Uzbekistan and relatively high rates of unfavorable treatment outcomes have recently been reported. This requires closer analysis to explain the reasons and recommend interventions to improve the situation. Thus, by using countrywide data this study sought to determine trends in unfavorable outcomes (lost-to-follow-ups, deaths and treatment failures) and describe their associations with socio-demographic and clinical factors.

METHOD

A countrywide retrospective cohort study of all new and previously treated TB patients registered in the National Tuberculosis programme between January 2006 and December 2010.

RESULTS

Among 107,380 registered patients, 67% were adults, with smaller proportions of children (10%), adolescents (4%) and elderly patients (19%). Sixty per cent were male, 66% lived in rural areas, 1% were HIV-infected and 1% had a history of imprisonment. Pulmonary TB (PTB) was present in 77%, of which 43% were smear-positive and 53% were smear-negative. Overall, 83% of patients were successfully treated, 6% died, 6% were lost-to-follow-up, 3% failed treatment and 2% transferred out. Factors associated with death included being above 55 years of age, HIV-positive, sputum smear positive, previously treated, jobless and living in certain provinces. Factors associated with lost-to-follow-up were being male, previously treated, jobless, living in an urban area, and living in certain provinces. Having smear-positive PTB, being an adolescent, being urban population, being HIV-negative, previously treated, jobless and residing in particular provinces were associated with treatment failure.

CONCLUSION

Overall, 83% treatment success rate was achieved. However, our study findings highlight the need to improve TB services for certain vulnerable groups and in specific areas of the country. They also emphasize the need to develop unified monitoring and evaluation tools for drug-susceptible and drug-resistant TB, and call for better TB surveillance and coordination between provinces and neighbouring countries.

摘要

背景

结核病是乌兹别克斯坦主要的卫生重点之一,最近有报告称不利治疗结果的发生率相对较高。这需要进行更深入的分析,以解释原因并推荐改善状况的干预措施。因此,本研究通过使用全国范围的数据,试图确定不利结果(失访、死亡和治疗失败)的趋势,并描述它们与社会人口学和临床因素的关联。

方法

对2006年1月至2010年12月在国家结核病项目中登记的所有新发病例和既往治疗过的结核病患者进行全国范围的回顾性队列研究。

结果

在107380名登记患者中,67%为成年人,儿童(10%)、青少年(4%)和老年患者(19%)的比例较小。60%为男性,66%生活在农村地区,1%感染艾滋病毒,1%有监禁史。77%为肺结核(PTB),其中43%痰涂片阳性,53%痰涂片阴性。总体而言,83%的患者得到成功治疗,6%死亡,6%失访,3%治疗失败,2%转出。与死亡相关的因素包括年龄在55岁以上、艾滋病毒阳性、痰涂片阳性、既往接受过治疗、失业以及生活在某些省份。与失访相关的因素包括男性、既往接受过治疗、失业、生活在城市地区以及生活在某些省份。痰涂片阳性肺结核、青少年、城市人口、艾滋病毒阴性、既往接受过治疗、失业以及居住在特定省份与治疗失败相关。

结论

总体而言,实现了83%的治疗成功率。然而,我们的研究结果突出表明,需要改善该国某些弱势群体和特定地区的结核病服务。它们还强调需要为药物敏感结核病和耐药结核病开发统一的监测和评估工具,并呼吁加强省级和邻国之间更好的结核病监测与协调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e578/4467982/7806842be372/pone.0128907.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e578/4467982/7806842be372/pone.0128907.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e578/4467982/7806842be372/pone.0128907.g001.jpg

相似文献

1
Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study.乌兹别克斯坦新患结核病患者和既往治疗过的结核病患者治疗效果不佳的相关因素:一项为期五年的全国性研究。
PLoS One. 2015 Jun 15;10(6):e0128907. doi: 10.1371/journal.pone.0128907. eCollection 2015.
2
Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan.复发性结核病及其相关因素:乌兹别克斯坦一项为期五年的全国性研究。
PLoS One. 2017 May 4;12(5):e0176473. doi: 10.1371/journal.pone.0176473. eCollection 2017.
3
Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005-2020), Republic of Karakalpakstan, Uzbekistan.与结核病患者不良治疗结局相关的因素:乌兹别克斯坦卡拉卡尔帕克斯坦共和国 16 年队列研究(2005-2020 年)。
Int J Environ Res Public Health. 2021 Dec 5;18(23):12827. doi: 10.3390/ijerph182312827.
4
Risk Factors for Unfavorable Treatment Outcomes among the Human Immunodeficiency Virus-Associated Tuberculosis Population in Tashkent City, Uzbekistan: 2013-2017.乌兹别克斯坦塔什干市人类免疫缺陷病毒相关结核病人群中不良治疗结局的危险因素:2013-2017 年。
Int J Environ Res Public Health. 2021 Apr 27;18(9):4623. doi: 10.3390/ijerph18094623.
5
Factors associated with unfavourable tuberculosis treatment outcomes in Lusaka, Zambia, 2015: a secondary analysis of routine surveillance data.2015年赞比亚卢萨卡与结核病治疗不良结局相关的因素:常规监测数据的二次分析
Pan Afr Med J. 2019 Apr 8;32:159. doi: 10.11604/pamj.2019.32.159.18472. eCollection 2019.
6
Magnitude and treatment outcomes of pulmonary tuberculosis patients in a poor urban slum of Abia State, Nigeria.尼日利亚阿比亚州一个贫困城市贫民窟中肺结核患者的患病程度及治疗结果
Int J Mycobacteriol. 2016 Jun;5(2):205-10. doi: 10.1016/j.ijmyco.2016.03.003. Epub 2016 Mar 24.
7
Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.结核治疗结局和预测因素在埃塞俄比亚北部监狱:五年回顾性分析。
BMC Pulm Med. 2018 Feb 20;18(1):37. doi: 10.1186/s12890-018-0600-1.
8
Predictors of tuberculosis treatment success among HIV-TB co-infected patients attending major tuberculosis treatment sites in Abeokuta, Ogun State, Nigeria.在尼日利亚奥贡州阿贝奥库塔主要结核病治疗点接受治疗的艾滋病毒与结核病合并感染患者中,结核病治疗成功的预测因素。
Pan Afr Med J. 2019 Jan 22;32(Suppl 1):7. doi: 10.11604/pamj.supp.2019.32.1.13272. eCollection 2019.
9
Tuberculosis in Poland in 2017.2017年波兰的结核病情况
Przegl Epidemiol. 2019;73(2):211-226.
10
Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands.荷兰常规治疗儿童和青少年结核病的治疗结果的全国性分析。
Eur Respir J. 2019 Dec 12;54(6). doi: 10.1183/13993003.01402-2019. Print 2019 Dec.

引用本文的文献

1
Forecasting tuberculosis in Ethiopia using deep learning: progress toward sustainable development goal evidence from global burden of disease 1990-2021.利用深度学习预测埃塞俄比亚的结核病:1990 - 2021年全球疾病负担研究中可持续发展目标的进展证据
BMC Infect Dis. 2025 Jul 1;25(1):870. doi: 10.1186/s12879-025-11228-3.
2
Tuberculosis treatment success rate and its predictors among TB HIV co-infected patients in East and North Eastern Uganda.乌干达东部和东北部结核病与艾滋病毒合并感染患者的结核病治疗成功率及其预测因素。
Sci Rep. 2025 Feb 14;15(1):5532. doi: 10.1038/s41598-024-85039-y.
3
Role of ethnicity and residency in active tuberculosis in Karakalpakstan: study protocol of a matched case-control study.

本文引用的文献

1
Fifteen-year trend in treatment outcomes among patients with pulmonary smear-positive tuberculosis and its determinants in Arsi Zone, Central Ethiopia.埃塞俄比亚中部阿尔西地区痰涂片阳性肺结核患者治疗结果的15年趋势及其决定因素
Glob Health Action. 2014 Sep 19;7:25382. doi: 10.3402/gha.v7.25382. eCollection 2014.
2
Profile and response to anti-tuberculosis treatment among elderly tuberculosis patients treated under the TB Control programme in South India.印度南部结核病控制项目下老年结核病患者的概况及抗结核治疗反应
PLoS One. 2014 Mar 11;9(3):e88045. doi: 10.1371/journal.pone.0088045. eCollection 2014.
3
Risk factors associated with default from multi- and extensively drug-resistant tuberculosis treatment, Uzbekistan: a retrospective cohort analysis.
卡拉卡尔帕克斯坦活动性肺结核中种族和居住地点的作用:一项匹配病例对照研究的研究方案。
BMJ Open Respir Res. 2024 Oct 26;11(1):e002554. doi: 10.1136/bmjresp-2024-002554.
4
Effect of Cost-Exemption Policy on Treatment Interruption in Patients With Newly Diagnosed Pulmonary Tuberculosis in South Korea.韩国新诊断肺结核患者免费用药政策对治疗中断的影响。
Int J Health Policy Manag. 2024;13:8262. doi: 10.34172/ijhpm.8262. Epub 2024 Jul 14.
5
Evaluating tuberculosis treatment outcomes in Haiti from 2018 to 2019: A competing risk analysis.评估2018年至2019年海地的结核病治疗结果:一项竞争风险分析。
IJID Reg. 2024 Mar 13;11:100350. doi: 10.1016/j.ijregi.2024.03.005. eCollection 2024 Jun.
6
Nutritional status and treatment outcomes of tuberculosis in Mizan Tepi University Teaching Hospital, a five -year retrospective study.米赞特皮大学教学医院结核患者的营养状况和治疗结果:一项为期五年的回顾性研究。
PLoS One. 2024 Feb 15;19(2):e0298244. doi: 10.1371/journal.pone.0298244. eCollection 2024.
7
Prevalence and predictive factors of tuberculosis treatment interruption in the Asia region: a systematic review and meta-analysis.亚洲地区结核病治疗中断的流行情况及预测因素:系统评价和荟萃分析。
BMJ Glob Health. 2023 Jan;8(1). doi: 10.1136/bmjgh-2022-010592.
8
Determinants of unsuccessful tuberculosis treatment outcome in Northern Red Sea region, Eritrea.厄立特里亚北红海地区结核病治疗失败结局的决定因素。
PLoS One. 2022 Aug 15;17(8):e0273069. doi: 10.1371/journal.pone.0273069. eCollection 2022.
9
Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005-2020), Republic of Karakalpakstan, Uzbekistan.与结核病患者不良治疗结局相关的因素:乌兹别克斯坦卡拉卡尔帕克斯坦共和国 16 年队列研究(2005-2020 年)。
Int J Environ Res Public Health. 2021 Dec 5;18(23):12827. doi: 10.3390/ijerph182312827.
10
Operational Research to Inform Programmatic Approaches to the Management of Tuberculosis in Uzbekistan.运用运筹学方法为乌兹别克斯坦结核病规划管理提供信息支持。
Int J Environ Res Public Health. 2021 Nov 23;18(23):12308. doi: 10.3390/ijerph182312308.
与多药和广泛耐药结核病治疗失败相关的风险因素,乌兹别克斯坦:回顾性队列分析。
PLoS One. 2013 Nov 6;8(11):e78364. doi: 10.1371/journal.pone.0078364. eCollection 2013.
4
Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011.乌兹别克斯坦的耐多药结核病:2010 至 2011 年全国调查结果。
Euro Surveill. 2013 Oct 17;18(42):20609. doi: 10.2807/1560-7917.es2013.18.42.20609.
5
Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India.印度孟买一组接受耐多药结核病治疗的 HIV 感染青少年的不良结局。
PLoS One. 2013 Jul 19;8(7):e68869. doi: 10.1371/journal.pone.0068869. Print 2013.
6
The profile and treatment outcomes of the older (aged 60 years and above) tuberculosis patients in Tamilnadu, South India.印度南部泰米尔纳德邦老年(60 岁及以上)结核病患者的特征和治疗结果。
PLoS One. 2013 Jul 8;8(7):e67288. doi: 10.1371/journal.pone.0067288. Print 2013.
7
Impact of diabetes and smoking on mortality in tuberculosis.糖尿病和吸烟对结核病死亡率的影响。
PLoS One. 2013;8(2):e58044. doi: 10.1371/journal.pone.0058044. Epub 2013 Feb 28.
8
Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi.马拉维一家结核病/艾滋病诊所中,根据 HIV 和抗逆转录病毒状态比较新的涂片阳性肺结核患者的治疗结局。
PLoS One. 2013;8(2):e56248. doi: 10.1371/journal.pone.0056248. Epub 2013 Feb 15.
9
Tuberculosis treatment outcome monitoring in European Union countries: systematic review.欧盟国家结核病治疗结局监测:系统评价。
Eur Respir J. 2013 Mar;41(3):635-43. doi: 10.1183/09031936.00030612. Epub 2012 Jul 12.
10
Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes.低发国家 HIV 阴性和 HIV 阳性患者中的结核病:临床特征和治疗结局。
PLoS One. 2012;7(3):e34186. doi: 10.1371/journal.pone.0034186. Epub 2012 Mar 30.